Related Experiment Video

Updated: Dec 29, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

8.0K

Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?

Vildan B Cetintas1,2, Nizar N Batada3

  • 1Department of Medical Biology, Faculty of Medicine, Ege University, Izmir, Turkey.

Journal of Translational Medicine
|February 1, 2020
PubMed

Insights

PTEN deficiency impairs anti-tumor immunity by altering immune cell levels and inflammatory signals, potentially mediated by interferon pathways. This link offers new avenues for personalized PTEN-deficient cancer immunotherapy.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • The PTEN tumor suppressor gene is frequently inactivated in various cancers.
  • PTEN's established roles in PI3K/AKT and DNA damage pathways are known.
  • Emerging evidence suggests PTEN influences anti-tumor immunity.

Purpose of the Study:

  • To review the mechanistic link between PTEN deficiency and the immunosuppressive tumor microenvironment.
  • To explore the role of the interferon signaling pathway in PTEN-mediated immunity.
  • To discuss therapeutic strategies for PTEN-deficient tumors based on these interactions.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of molecular mechanisms connecting PTEN, immunity, and interferon signaling.
  • Discussion of preclinical and clinical implications.

Main Results:

  • PTEN-deficient tumors exhibit reduced cytotoxic and helper T cells, NK cells.
  • Elevated pro-tumorigenic cytokines (e.g., CCL2) and immunosuppressive cells (MDSCs, Tregs) are characteristic.
  • The interferon signaling pathway is implicated as a mediator between PTEN status and immune evasion.

Conclusions:

  • PTEN deficiency creates an immunosuppressive tumor microenvironment.
  • Interferon signaling is a key pathway linking PTEN loss to immune suppression.
  • Targeting the PTEN-interferon axis may enable personalized immunotherapies for PTEN-deficient cancers.
Keywords:
Immunosuppressive tumor microenvironmentImmunotherapy resistanceInnate immunityInterferonPTENcGAS/STING

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.3K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.3K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K